CpG-creating mutations are costly in many human viruses

Area of Science:

• Virology
• Genomics
• Evolutionary Biology

Background:

• Mutations are central to viral genome evolution, with varying impacts (beneficial, neutral, deleterious).
• CpG sites (cytosine followed by guanine) are notably rare in eukaryotic and viral genomes.
• Methylation-driven mutation is a proposed reason for CpG rarity in eukaryotes, but less is understood for viruses.

Purpose of the Study:

• To investigate the evolutionary cost of CpG-creating mutations in diverse viral genomes.
• To determine if the higher cost of CpG-creating mutations observed in HIV extends to other viruses.

Main Methods:

• Analysis of allele frequencies of mutations across various viral strains, subtypes, and genes.
• Utilized existing viral genomic data from Genbank, HIV Databases, and Virus Pathogen Resource.
• Compared the frequency and impact of CpG-creating mutations versus non-CpG-creating mutations.

Main Results:

• CpG sites were found to be costly for the majority of viruses analyzed.
• The findings support the hypothesis that CpG sites represent a mutational burden in viral populations.
• This cost likely influences viral genome composition and evolutionary trajectories.

Conclusions:

• CpG sites impose a significant evolutionary cost on most viruses.
• Understanding this cost provides critical insights into viral adaptation and evolution.
• The rarity of CpG sites is a conserved feature across many viral systems due to mutational constraints.